Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-10 Purchase | 2022-03-14 5:38 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 226,000 | $0.67233 | $151,946 | 47,988,442 (Indirect Direct) | View |
| 2022-03-03 Purchase | 2022-03-07 6:09 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 510,000 | $0.67477 | $344,133 | 47,762,442 (Indirect Direct) | View |
| 2022-02-24 Purchase | 2022-02-28 5:53 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 140,000 | $0.79861 | $111,806 | 47,252,442 (Indirect Direct) | View |
| 2022-02-17 Purchase | 2022-02-22 6:37 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 288,000 | $0.80404 | $231,564 | 47,112,442 (Indirect Direct) | View |
| 2022-01-18 Purchase | 2022-01-20 6:14 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 312,000 | $0.87976 | $274,486 | 46,824,442 (Indirect Direct) | View |
| 2022-01-12 Purchase | 2022-01-14 5:49 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 455,000 | $0.99509 | $452,768 | 46,512,442 (Indirect Direct) | View |
| 2022-01-07 Purchase | 2022-01-11 6:18 pm | Avalo Therapeutics Inc. | AVTX | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven Director 10% Owner | 645,000 | $0.99679 | $642,931 | 46,057,442 (Indirect Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 6:19 pm | Avalo Therapeutics Inc. | AVTX | Wilkins H Jeffrey Chief Medical Officer | 6,371 | $1.57 | $10,002 | 33,373 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:17 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan CAO | 955 | $1.57 | $1,499 | 9,004 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:16 pm | Avalo Therapeutics Inc. | AVTX | Harrell James Archie Jr Chief Commercial Officer | 1,093 | $1.57 | $1,716 | 36,766 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:15 pm | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Scientific Officer | 4,267 | $1.57 | $6,699 | 85,639 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:13 pm | Avalo Therapeutics Inc. | AVTX | Greenway Schond L. CFO | 2,231 | $1.57 | $3,503 | 3,883 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-30 Option Award | 2022-07-05 5:34 pm | 2022-06-30 2032-06-30 | Avalo Therapeutics Inc. | AVTX | Persson Magnus Director | 26,837 | $0 | 26,837 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-01 4:07 pm | 2022-06-30 2032-06-30 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 44,115 | $0 | 44,115 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-01 4:00 pm | 2022-06-30 2032-06-30 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 4,338 | $0 | 4,338 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:01 pm | 2023-06-14 2032-06-14 | Avalo Therapeutics Inc. | AVTX | Persson Magnus Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:30 pm | 2023-06-14 2032-06-14 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:23 pm | 2023-06-14 2032-06-14 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:15 pm | 2023-06-14 2032-06-14 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 6:25 pm | 2022-03-31 2032-03-31 | Avalo Therapeutics Inc. | AVTX | Persson Magnus Director | 18,468 | $0 | 18,468 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 6:06 pm | 2022-03-31 2032-03-31 | Avalo Therapeutics Inc. | AVTX | Miller Joseph M Director | 20,239 | $0 | 20,239 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:37 pm | 2022-03-31 2032-03-31 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 30,359 | $0 | 30,359 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:13 pm | 2022-03-31 2032-03-31 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 2,985 | $0 | 2,985 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-10 5:50 pm | N/A 2032-03-08 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan CFO | 450,000 | $0 | 450,000 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-10 5:38 pm | N/A 2032-03-08 | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 4:19 pm | N/A 2032-01-04 | Avalo Therapeutics Inc. | AVTX | Smolinski Stephen Chief Commercial Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:28 pm | 2021-12-31 2031-12-31 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 737 | $0 | 737 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:26 pm | 2021-12-31 2031-12-31 | Avalo Therapeutics Inc. | AVTX | Persson Magnus Director | 7,943 | $0 | 7,943 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:25 pm | 2021-12-31 2031-12-31 | Avalo Therapeutics Inc. | AVTX | Miller Joseph M Director | 8,920 | $0 | 8,920 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:23 pm | 2021-12-31 2031-12-31 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 12,767 | $0 | 12,767 (Direct) | View |
| 2021-12-01 Option Award | 2021-12-03 8:44 pm | N/A 2031-12-01 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-11-10 Option Award | 2021-11-12 4:18 pm | N/A 2031-11-10 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:48 pm | 2021-09-30 2031-09-30 | Avalo Therapeutics Inc. | AVTX | Bruhn Suzanne Louise Director | 5,204 | $0 | 5,204 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:45 pm | 2021-09-30 2031-09-30 | Avalo Therapeutics Inc. | AVTX | Gutry Phil Director | 4,718 | $0 | 4,718 (Direct) | View |